{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:25:00Z","timestamp":1793975100254,"version":"4.8.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.metop.2026.100509","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:31:53Z","timestamp":1791588713000},"page":"100509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GLP-1R agonism in breast cancer: a metabolic\u2013oncogenic switch?"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0798-6262","authenticated-orcid":false,"given":"Angeliki","family":"Margoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-745X","authenticated-orcid":false,"given":"Kostas A.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4527","authenticated-orcid":false,"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2026.100509_bib1","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/life15101634","article-title":"Translating metabolic interventions into breast cancer therapy: a comprehensive review","volume":"15","author":"Chen","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.metop.2026.100509_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101923","article-title":"Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K\/Akt\/mTOR signaling pathway","volume":"32","author":"Alanteet","year":"2024","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.metop.2026.100509_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70913","article-title":"The GLP-1 receptor agonist liraglutide promotes anticancer activities in MCF7 breast and PC-3 prostate cancer cells by modulating glycolysis, oxidative stress and adipokines","volume":"40","author":"Refaat","year":"2026","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.metop.2026.100509_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/OP-26-00485","article-title":"GLP-1 agonists are associated with a significant reduction in breast cancer incidence in women","volume":"22","author":"McDonald","year":"2026","journal-title":"JCO Oncol Pract"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993682600068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993682600068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:28:39Z","timestamp":1793971719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258993682600068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":4,"alternative-id":["S258993682600068X"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2026.100509","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1R agonism in breast cancer: a metabolic\u2013oncogenic switch?","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2026.100509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100509"}}